Efficacy of low dose naltrexone for patients that suffer from comorbid depressive illness
The 15th Pacific Rim College of Psychiatrists Scientific Meeting
October 2012
https://onlinelibrary.wiley.com/doi/pdf/10.1111/appy.12002
This study is a retrospective chart review meant to investigate the efficacy of low dose naltrexone (LDN) for the treatment of patients with co-morbid depression and collagen disease. At week 4, 80% of patients experienced a certain degree of improvement with LDN.